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Abstract 
Obesity is arguably the biggest health and welfare issue affecting pet dogs.  Although successful 
weight loss has health benefits, current strategies are far from ideal.  Many obese dogs that start a 
weight programme fail to lose weight, or subsequently regain the weight they have lost.  Given 
that current weight loss strategies are not perfect, clinicians need to focus carefully on tailoring 
the programme, perhaps setting a pragmatic target for weight loss, so as to ensure the benefits are 
maximised.  This review will summarise key findings from recent clinical research into pet 
obesity, and present a framework for improving success, by better tailoring weight management 
regimes and end points to the individual. 
  
The significance of obesity in pets 
The medical profession now classifies human obesity as a disease,(1) with the condition 
predisposing to numerous other diseases including: type II diabetes mellitus, cardiovascular 
disease (e.g. coronary heart disease, atherosclerosis, and hypertension),  renal disease (typically 
secondary to diabetic nephropathy), liver disease (e.g. steatosis, cirrhosis and hepatocellular 
carcinoma), osteoarthritis, respiratory impairment (e.g. obstructive sleep apnoea and asthma), 
and neoplasia (e.g. breast, prostatic, ovarian, colonic/rectal, renal cell and oesophageal 
cancer.(2,3,4,5)  Not surprisingly, obesity conveys increased risk of mortality to affected human 
subjects(6).  Similarly, the veterinary profession now recognises obesity to be the most important 
medical disease in dogs,(7) with published studies suggesting that 34-59% of dogs(8-10) are either 
overweight or obese.  Although published evidence is limited, the prevalence of canine obesity 
appears to be gradually increasing.(11)  As with obesity in man, overweight dogs are at risk of 
developing other diseases such as diabetes mellitus, osteoarthritis, and urinary incontinence, as 
well as altered respiratory function.(12,13)  Metabolic derangements also arise,(14-17) and there are 
alterations in renal function.(18)  All in all, obesity adversely affects quality of life,(19) and 
shortens lifespan.(20)  Given these adverse affects on health and quality of life, canine obesity 
presents a major welfare challenge for veterinary surgeons. 
 
A variety of predisposing factors may contribute to the development of obesity in dogs, and these 
including underlying diseases (e.g. hypothyroidism and hyperadrenocorticism), breed 
predispositions (e.g. Labrador retriever, Cairn terrier, cavalier King Charles spaniel, Scottish 
terrier, cocker spaniel), and neutering.(7,9)  In addition, owner and lifestyle factors might 
contribute with examples including: socioeconomic status, middle age, apartment dwelling, 
physical inactivity, and a lesser interest in preventive veterinary care.(9,21,22,23)  Dietary factors 
have also been implicated such as food type and the use of treats and table scraps(21,22) 
 
Overview of obesity management 
In humans, bariatric surgery is the most successful approach for treatment of obesity, but this is 
not ethically justifiable or practical in dogs.  For a while, the microsomal membrane transfer 
protein (MTP) inhibitor drugs, dirlotapide and mitratapide, were approved for controlled weight 
loss, and good efficacy was reported from clinical trials.(24,25)   However, performance in clinical 
practice was disappointing and both drugs have now been withdrawn.  Therefore, the use of a 
purpose-formulated diet remains the principle method for controlled weight loss, usually in 
conjunction with changes in lifestyle designed to increase activity and control feeding of extra 
food (e.g. as treats or table scraps).(26-29) 
 
Rather than simply reducing body weight to reach a nominal target, the main aims of weight 
management are to improve quality of life and reduce associated disease risk.  To ensure long-
term success, weight management involves not only the controlled weight loss phase, but also 
subsequent weight maintenance so as to stabilise body weight and prevent rebound.  Unless, 
owner habits are changed permanently, to ensure a healthier relationship develops between the 
dog and its owner, weight management will fail in the long run. 
 
Dietary management 
Purpose-formulated weight loss diets are recommended because they have a restricted energy 
content whilst, at the same time, being supplemented in protein and micronutrients.  Altering the 
macronutrient content of a weight management diet can also improve satiety, especially when 
fibre is supplemented.  However, in dogs supplementing both protein and fibre relative to energy 
content provides the greatest benefit,(30) and such a formulation improves outcome of weight 
loss.(28) 
 
Food intake during weight loss should be accurately calculated, and based upon the estimated 
ideal weight rather than current weight.  The exact recommendation the level of energy intake 
during the weight loss period can vary depending upon the food used, sex, whether the dog has 
been neutered, and if there is any concurrent disease.  The owner should be taught to measure 
food out precisely using electronic gram scales; measuring cups should not be used because 
measurements are imprecise and commonly lead to overfeeding.  If possible, the feeding of any 
additional food (in the form of treats, table scraps or scavenged food) should be avoided.  If this 
is not acceptable to the owner, certain healthy treats could be sanctioned, as long as they are 
taken into account in the energy intake calculations and, ideally, provide <5% of total daily 
requirements. 
 
Lifestyle management 
Increasing physical activity is also recommended for most weight management programmes, 
since there are many benefits.  Activity is thought to help preserve lean tissue mass, and promote 
the loss of adipose tissue instead.  The activity plan should be tailored to the individual and take 
into account the capabilities of the owner, as well as any concurrent medical diseases that the 
animal has. Suitable exercise strategies in dogs include lead walking, playing, swimming, 
hydrotherapy, and the use of puzzle feeders. 
 Monitoring of weight loss 
To ensure success, any weight loss protocol requires close monitoring, typically by scheduling 
regular measurements of body weight.  At the start, most clinicians choose to undertake such 
checks every 2 weeks, but the interval can be altered if consistent progress is made, and it better 
suits the owner.  The same set of electronic scales should be used, to ensure consistency.(27)  
Body weight checks should be continued periodically after target weight has been reached, in 
order to reduce the likelihood of rebound occurring (see below). 
 
Benefits of weight loss 
As mentioned above, obesity can have a number of adverse effects on health, including 
shortening lifespan, predisposing to disease, causing metabolic and functional derangements, and 
worsening the severity of pre-existing disease.  Whilst it is commonly suggested that successful 
weight loss may have positive impact on all of these adverse effects, there is limited direct 
evidence for this.  The author is not aware of any studies that convincingly demonstrate that 
weight loss leads to either increases in lifespan or decreased disease risk.  However, there is 
emerging evidence of benefits to function and alleviation of concurrent disease severity.  For 
instance, even modest weight loss (e.g. exceeding 6%) can improve mobility in obese dogs with 
concurrent osteoarthritis.(31,32)  Improvement in respiratory function is also seen when obese dogs 
lose weight.(13)  Further, there is evidence of improved insulin sensitivity and other metabolic 
derangement when successful weight loss occurs.(16-18)  Thus, whilst clinicians should be 
cautious in overstating the benefits of weight loss, there are clear-cut improvements in health that 
can be emphasised. 
 Of course, the benefits of weight loss should not only be judged by improvements in health.  
Arguably, poor quality of life has at least at much impact on wellbeing.  In a recent study, a 
validated questionnaire was used to assess quality of life, which was scored using four factors: 
vitality (assessing activity levels), chronic pain, as well as anxiety and emotional disturbances, 
(both assessing psychological effects on quality of life).(19)  The questionnaire was completed 
when dogs were obese, and repeated after successful weight loss, enabling changes in quality of 
life to be assessed.  Overall, quality of life scores were low when dogs were obese, and improved 
in the dogs that successfully lost weight.  In particular, vitality scores increased, whilst emotional 
disturbance and pain scores decreased.  Changes in body composition were concurrently 
assessed using dual-energy X-ray absorptiometry (DEXA), and demonstrated that changes in 
vitality score were positively correlated with changes in body fat mass. 
 
Outcomes of weight loss in obese dogs and cats 
Rate of weight loss and energy intake during weight management 
When assessed in a colony setting, weight loss protocols for obese dogs are very successful with 
typical rates of weight loss consistently over 1%/week, when restricting caloric intake to 50-75% 
of maintenance energy requirements.(33-36)  Whilst there are many advantages to performing such 
studies in a colony, most notably in consistency and control, the results are not necessarily 
representative of how obese dogs lose weight when supervised by their owners.   
 
In light of this, some recent studies have assessed weight loss in cohorts of obese pet dogs.  
Weight loss is typically slower, with a typical rate of weight loss of 0.5-1.0% of starting 
bodyweight (SBW) per week.(27,37) Despite this slower rate, a greater degree of energy restriction 
is needed, typically 55-65% of maintenance energy requirement at target weight).(27,37)  There 
may be various reasons why outcomes differ between colony research and studies using pet 
dogs, but owner compliance is likely to be a major factor.  When owners are responsible for 
overseeing their dog’s weight loss programme, non-compliance is common with self-reports 
confirming that additional food (e.g. treats and table scraps) is given against veterinary advice, 
and this could represent as much as 10% of MER.10,13  Such non-compliance is most likely to 
caused by increased begging and scavenging activity in the dog, which itself arises from the 
energy restriction imposed.  Dietary strategies can be used to minimise the development of these 
behaviours, for instance using particular macronutrient profiles to reduce hunger.  For example, 
increasing both the protein and fibre content of a food reduces voluntary food intake,14 and 
feeding such a food to obese dogs improves success, in terms of faster rates of weight loss and 
greater fat loss than with standard weight loss diets.11 
 
Changes in body composition during weight loss 
A number of colony studies have assessed body composition during weight loss, and some of 
these infer that tissue mass is exclusively lost from the adipose tissue compartment.(24,36)  
However, such studies typically only examine modest amounts of weight loss (often 10-20%).  
Work in obese pet dogs undergoing controlled weight loss have contradicted these findings, and 
revealed that lean tissue loss is inevitable in most animals.(27,37)  The discrepancy between colony 
and clinical studies can readily be explained by the fact that significantly more weight loss is 
required to return an obese pet dog to its ideal weight than is typically assessed in a colony study; 
for example, median weight lost in one such study was 25%, with some dogs losing over 40%.(27)  
It is now known that the magnitude of lean tissue loss increases in proportion to the overall 
percentage of weight lost,(18,27), meaning that lean tissue loss is really only an issue when dogs 
lose more than 20% of their starting body weight. 
 
Likelihood of successfully reaching target weight 
Whilst a number of clinical studies have now been conducted to determine the outcomes of 
weight management in obese dogs, most studies are only of short duration, assessing the initial 
phase of weight loss (e.g. the first 2-3 months).(26,29,32,36)  Such work certainly provides useful 
information on the early stages of a weight loss protocol, such as initial rate and initial energy 
intake required for weight loss.  However, the duration of study is usually not sufficient to 
capture outcomes of a complete weight loss cycle.  Arguably, studies that assess the whole of the 
weight loss period and beyond are most realistic and valuable for the veterinary profession.  
Further, studies rarely examine compliance with the programme or overall success, in terms of 
the proportion of dogs that start a programming who actually complete it.  Studies of human 
obesity have demonstrated that rate of weight loss tends to plateau after about 6 months on diet-
based weight loss program, meaning that most people never reach their target weight,(38) and 
often then regain the weight they originally lost.(39)  The author is aware of only one previous 
canine study that assessed actual success.(29)  In this study, about half of dogs completed a 6-
month programme, but it unclear whether they actually reached target in this time.  In a recent 
study, the records of obese dogs attending a weight management referral clinic were reviewed, 
and cases were classified according to their outcome (i.e. whether or not they had completed or 
stopped their programme).(37)  Factors associated with the likelihood of reaching target weight 
were assessed with simple and multiple logistic regression.  Of the 143 dogs included, 87 (61%) 
completed the programme and reached their target weight.  The remaining dogs stopped 
prematurely, either because they were euthanased (for an unrelated reason; 11 [8%]), or because 
the owners chose to stop (45 [32%]). Reasons for dogs stopping the programme included owners 
refusing to comply with the requirements of the weight loss programme, because their dog 
developed another disease, or for personal reasons.  Simple and multiple logistic regression 
analysis revealed that dogs fed a dry weight loss diet were more likely to complete the 
programme that those on wet food or a mix of wet and dry food, whilst the most overweight dogs 
(i.e. those with the greatest starting body fat determined by DEXA) dogs were far less likely to 
complete.  Whilst these findings may be somewhat disappointing, it should at least be 
remembered that over 85% of the dogs did lose >6%, the magnitude where another study 
observed measurable health benefits.(32) 
 
Outcomes at different stages of a complete weight loss cycle 
As mentioned above, most existing studies assessing weight loss in obese dogs only examine the 
early stages, and this is not representative of a complete weight loss cycle.  In light of this, a 
recent study reported a range of outcomes at key stages during a complete weight loss cycle.(40)  
Outcomes examined included rate of weight loss, percentage weight loss, and energy intake, and 
status (e.g. still on programme, completed, stopped, or euthanased).  Rate of weight loss was 
relatively fast in the early stages (e.g. 1.2 ±0.67% starting body weight per week), but had 
steadily decline to a rate of just 0.1 ±0.1% starting body weight per week by day 672 (Figure 1).  
This decline in rate happened despite a gradually reducing energy intake throughout weight loss 
(Figure 2).  In the early stages, compliance was good (e.g. 86%) and dogs has lost ~11% body 
weight on average.  However, very few had completed their programme within this time.  
Thereafter, many dogs did start to reach target, but the number of discontinuing steadily 
increased such that, by day 672, 59% had completed and 32% had stopped.  These results 
highlight the fact that initial weight loss is usually good, but the response steadily worsens 
thereafter.  It also confirms the fact that, unless the complete weight loss cycle is examined, the 
results of weight loss studies can be misleading. 
 
The rebound phenomenon 
One final limitation with most clinical weight loss studies is the fact that they only look at the 
weight loss phase, and do not examine subsequent maintenance of weight.  Arguably, 
permanently keeping weight off is more important than losing it in the first place, in order that 
any benefits in quality of life be maintained.  Long-term success is disappointing for obese 
people who lose weight through dietary means, with studies suggesting that some participants 
regain more weight than they had originally lost.(39)  A recent study has examined follow-up after 
reaching target weight in obese pet dogs.(41)  Of the 33 dogs studied, 14 (42%) of dogs 
maintained weight, 3 (9%) lost further weight, and 16 (48%) regained weight.  However, whilst 
rebound was common, its magnitude (median weight change +4%) was typically less than that 
seen in similar human studies, meaning that the majority of dogs kept much of the weight off.  
The likelihood of regaining weight was significantly less if the purpose-formulated weight 
management diet continued to be fed during weight maintenance, rather than switching back 
onto a standard maintenance diet.  This study highlights the fact that weight management is a 
lifelong process with clinicians needing to continue to monitor body weight after ideal weight 
has been achieved. 
 
How can we do better? 
As described above, clinical research about weight management in obese pet dogs has revealed a 
number of key insights into both the success of the weight management process, but also the 
challenges it brings, and the realities in terms of long-term outcomes.  Clinicians must accept 
that current strategies are not perfect, and that many animals will fail.  To recap, the following 
clinically proven facts should be considered: 
 
• There are potential health and welfare benefits when an obese dog loses weight.  
Clinically proven benefits of weight loss include lessening the impact of existing medical 
conditions, normalising metabolic derangements including insulin resistance, improving 
organ function (notably respiratory system and kidneys), and improving overall quality of 
life.  Although not proven, the association between overweight body condition and 
shortened lifespan might also suggest that weight loss could extend life.  In a similar 
manner the associations between overweight condition and a range of diseases, might 
mean that other diseases might be avoided. 
• Weight management is challenging for owner and pet.  Successful weight loss in 
obese pet dogs and cats is more challenging than suggested by research conducted in 
colony studies.  Weight loss progresses more slowly, and marked energy restriction is 
required.  The rate of weight loss declines steadily during the weight management 
process, and requires steadily more energy restriction.  This can lead to frustration for the 
owner, and the increased begging activity that can result may mean that owners do not 
comply with the programme. 
• Weight management can lead to loss of lean tissue.  Lean tissue loss is a potential 
effect of the weight loss process, but is mainly a feature for dogs losing more than 20% of 
body weight. 
• Not all obese dogs and cats succeed in losing weight.  Just over half of dogs starting a 
weight loss protocol succeed in reaching their target weight.  Compliance is good in the 
early stages of weight loss with over 80% remaining on the programme, but few have 
reached target weight in this time.  The dropout rate increases steadily after 3 months, 
meaning that only about half of all obese animals are actually likely to reach target.  Not 
surprisingly, dogs with the most weight to lose are least likely to be successful because 
the process  
• Most dogs lose some weight, even if they do not reach target.  Although many dogs 
and cats are unsuccessful, the majority will lose some weight in the early stages, and 
generally more than 6% weight. 
 
Most importantly, the weight loss process in obese dogs is a clear example of diminishing 
returns, namely that the more weight that must be lost, the more difficult it is.  The payoff of 
success in these circumstances is dramatic energy restriction, and the likelihood of some lean 
tissue loss.  In the author’s opinion the process of tailoring weight management to the 
individual is key to maximising success.  This concept involves understanding the priorities for 
weight management for each case, setting case-specific targets, and establishing a realistic plan 
that will maximise the chance of benefitting the patient long-term.  Broadly speaking, two 
strategies could be considered, complete weight loss and partial weight loss.  As the name 
suggests, the purpose of a complete weight loss programme would be to return the dog to its 
ideal weight.  In contrast, with a partial weight loss programme, a target weight is deliberately 
set which is above the ideal weight. 
 
Complete weight loss has the benefits of ‘normalising’ adipose tissue mass, with the aim of 
producing the maximal benefit to health in terms of improving metabolic status and organ 
function.  Although not proven, returning a dog to ideal condition, and keeping it there might 
also increase the likelihood of a longer lifespan.  Such an approach would be most applicable 
where obesity develops early in life i.e. young adulthood, where rapid return to normal weight 
would maximise any potential for extending lifespan.  A complete weight loss strategy might 
also be beneficial for obese dogs that do not yet have an obesity-associated disease, since many 
such diseases, for instance osteoarthritis, are chronic in nature developing insidiously over many 
years.  Once again, return to ideal weight would reduce the impact of obesity on the chronic 
disease process, thereby delaying its onset or preventing signs from manifesting at all. 
 
The disadvantage of a complete weight loss programme is the fact that the chance of failure is 
greater, and there is a risk that any weight initially lost might be regained again.  Further, as 
mentioned above, there is no evidence yet available that potential benefits such as increase 
lifespan and disease prevention actually occur.  Moreover, such benefits are less likely to be 
pertinent for older animals and for those with pre-existing disease.  Instead, the main priorities 
for weight management should be to improve quality of life and to lessen the impact of any 
concurrent disease.  In this respect, evidence is available that modest amounts of weight loss 
(e.g. ≥ 6%) can lead to alleviation of signs of concurrent disease such as osteoarthritis.(32)  
Devising a shorter-term plan with a more realistic target might be preferable for such dogs, and 
the clinician could be confident that over 80% would succeed.  Of course, if progress is good at 
that stage and if the owner is willing, the weight loss programme could be extended further. 
 
Conclusions 
Obesity is a major issue in pet dogs, and dietary strategies can be very successful.  However, it 
can be challenging to reach target weight, especially for the most obese animals.  Tailoring the 
weight loss plan involves not only devising an appropriate management strategy, in terms of 
dietary energy restriction and increased activity, but also setting a realistic target weight.  
Returning an obese animal to ideal weight may not suit all, and may not be necessary to achieve 
the benefits, not least if these relate to alleviation of signs of pre-existing disease or improving 
quality of life. 
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Figure legends 
 
Figure 1.  Rate of weight loss in obese pet dogs at different stages of a weight loss 
programme.(40)  Rate of weight loss was relatively fast in the early stages (e.g. 1.2 ±0.67% 
starting body weight per week), but had steadily decline to a rate of just 0.1 ±0.1% starting body 
weight per week by day 672. 
 
Figure 2.  Energy intake in obese pet dogs at different stages of a weight loss programme.(40)  
Data are expressed as kilocalories per kg of metabolic body weight (e.g. kg0.75) per day.  Energy 
intake gradually declines as weight loss progresses. 
 
